Xander Pharmaceuticals Private Limited
About Xander Pharmaceuticals Private Limited
Data last updated:
Xander Pharmaceuticals Private Limited is a private limited company based in Perintalmanna, Kerala, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 09 March 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN U24233KL2012PTC030714. Its GSTIN is 32AAACX1184F1ZN (Kerala).
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹20 Lakh. It is led by directors Raghunath Kolayambarampath (Whole-Time Director) and Kozhappilly Narayanan Kutty.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Perintalmanna, Kerala.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.56 Cr. For the same year it recorded a net profit of ₹32,987 (net margin 0.2%) and EBITDA of ₹60,187 (EBITDA margin 0.4%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Xander Pharmaceuticals Private Limited's registered office is in Perintalmanna, Kerala. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address2/530 C – D – E Anamangad P.O., Perinthalmanna Malappuram, Perintalmanna, Kerala, India – 679357
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Xander Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Xander Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
Financials of Xander Pharmaceuticals Private Limited
FY 2025 filings availableXander Pharmaceuticals Private Limited reported revenue of ₹1.56 Cr for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹60,187 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹32,987 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.4% | ||||
| Net Profit Margin | 0.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Xander Pharmaceuticals Private Limited, buy the company report.
Board of directors of Xander Pharmaceuticals Private Limited
Xander Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kozhappilly Narayanan Kutty | Director | 10 May 2024 | 2 Years 5 Months | Current |
| Raghunath Kolayambarampath | Whole-Time Director | 05 Apr 2014 | 12 Years 6 Months | Current |
Peer comparison
Xander Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Parixam Pharmaceuticals Private Limited | ₹1.56 Cr (FY 2023) | 1127.0% | Surat, Gujarat, India | |||
| Xander Pharmaceuticals Private Limitedthis company | ₹1.56 Cr (FY 2025) | ₹32,987 | 0.2% | Perintalmanna, Kerala, India | ||
| Vivion Pharmaceuticals Private Limited | ₹1.56 Cr (FY 2025) | 15.0% | Jaipur, Rajasthan, India | |||
| Mayapur Merchandise Private Limited | ₹1.56 Cr (FY 2025) | -37.0% | Kolkata, West Bengal, India | |||
| Kelly Pharmaceuticals Private Limited | ₹1.56 Cr (FY 2024) | 19.0% | Uttam Nagar, New Delhi, Delhi, India | |||
| Amstel Pharma Private Limited | ₹1.56 Cr (FY 2024) | 20.0% | Thrissur, Kerala, India |
To see the full peer comparison of Xander Pharmaceuticals Private Limited, buy the company report.
Auditor
Xander Pharmaceuticals Private Limited is audited by P.S. Ramesh & Co for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| P.S. Ramesh & Co | FY 2023 | 007929S |
Shareholding
The shareholding of Xander Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Xander Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Xander Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Xander Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Xander Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 32AAACX1184F1ZN | Kerala | Active | 24 Jan 2018 |
To see the full GST registrations and return filing status of Xander Pharmaceuticals Private Limited, buy the company report.
Recent activity
Xander Pharmaceuticals Private Limited has 5 board changes on record since 2014: 2 appointments and 3 cessations. The latest: David Joseph Palayoor ceased to be Director on 20 May 2024.
Frequently asked questions
Xander Pharmaceuticals is an active private limited company based in Perintalmanna, Kerala, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 09 March 2012 (14+ years old) and is registered under CIN U24233KL2012PTC030714.
Xander Pharmaceuticals has 2 current directors:
- Raghunath Kolayambarampath - Whole-Time Director
- Kozhappilly Narayanan Kutty - Director
The latest financial statements of Xander Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Xander Pharmaceuticals is 32AAACX1184F1ZN, registered in Kerala.
The CIN (Corporate Identification Number) of Xander Pharmaceuticals is U24233KL2012PTC030714. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Xander Pharmaceuticals was incorporated on 09 March 2012, making it 14+ years old. It is registered with the Registrar of Companies, Ernakulam.
The peers of Xander Pharmaceuticals by revenue are Parixam Pharmaceuticals Private Limited, Vivion Pharmaceuticals Private Limited, Mayapur Merchandise Private Limited, Kelly Pharmaceuticals Private Limited, Amstel Pharma Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
David Joseph Palayoor ceased to be Director on 20 May 2024. Raghunath Kolayambarampath ceased to be Director on 19 May 2024. Kozhappilly Narayanan Kutty was appointed as Director on 10 May 2024. Xander Pharmaceuticals has 5 board changes on record in total.
The registered office of Xander Pharmaceuticals is at 2530 C – D – E Anamangad P.O., Perinthalmanna Malappuram, Perintalmanna, Kerala, India – 679357.
Xander Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Xander Pharmaceuticals is compliant as of 31 July 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
